The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. We are a UK charity and member institution of the University of London.
September is Childhood Cancer Awareness Month (CCAM). Throughout the month, we highlight our latest work to improve the lives of children with cancer and our incredible family charity partners who support us all year round.
Scientists have discovered that a protein linked to prostate cancer is associated with more aggressive disease – it could be a new target for treatment and used to help predict who will become resistant to hormone therapy.
We are striving to improve the lives of people with all types of cancer – including those with the most challenging to treat. With your support today, we can defeat cancer.
Yvonne Diaz, 55, was diagnosed with stage 4 ALK-positive lung cancer in August 2021. She works in Communications and lives in Holland Park, London with her husband and twin sons, aged 17.
We are internationally renowned for driving scientific discoveries on cancer and came second of all UK universities in analysis of the 2021 Research Excellence Framework.
We aim to attract the best scientific minds who will be working at the forefront of cancer research, in an environment that’s collaborative, international and inclusive.
Our competitive PhD programme is designed for the next generation of world-leading cancer researchers who will benefit from exceptional research facilities.
Our research is made possible by our generous community of donors and supporters. Help transform the lives of people with cancer.
We draw upon our excellent scientists and facilities to further our world-class cancer research. We work with funders to deliver major research centres and collaborations.
Help sustain our research into the future and improve the lives of more cancer patients, by making a regular donation.
The ICR conducts research into many different types of cancer, from common cancers such as breast and prostate, to rarer diseases such as rhabdomyosarcoma.
We always want to hear from people who have a cancer story to share. Get in touch and help raise awareness of our research.
The ICR-CTSU leads high-quality international cancer clinical trials, and their findings directly influence clinical practice within the NHS and worldwide.
The ICR and Imperial College London are working together to open up new frontiers in cancer research.
Search is our supporter newsletter. Subscribe to read our latest news and research, as well as interviews with our world-leading scientists and clinicians.
Our state-of-the-art drug discovery centre will enable us to create more and and better cancer drugs
"I'm just so grateful for research" – Shelley's story
“Becoming a cancer patient has given me extra perspective” – Paul’s story